Clover Health Investments Corp. Hits New 52-Week High at $4.22

Clover Health Investments Corp., a small-cap player in the insurance industry, has reached a significant milestone by hitting a new 52-week high of USD 4.22 on May 28, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend over the past year. In terms of performance, Clover Health has outpaced the S&P 500, with a one-year performance rate of 28.45%. Despite being a loss-making entity, the company operates within a market cap of USD 1,093 million, indicating its position as a small-cap stock in the competitive insurance sector. Key financial metrics reveal a price-to-book ratio of 3.21, while the return on equity stands at -16.93%. The company does not currently offer a dividend, and its debt-equity ratio is notably high. As Clover Health continues to navigate the insurance landscape, this recent price milestone underscores its evolving market presence.